Inactive Instrument

Press Releases India Globalization Capital, Inc. Nyse

Equities

US45408X1000

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 16	IGC Pharma, Inc Announces Interim Data from Its Phase 2 Clinical Trial Demonstrates Clinically Significant Reduction, Approaching Statistical Significance, in Agitation in Alzheimer?S At Week Two Compared to Placebo	CI
Mar. 22	Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IGC PHARMA : Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation	Apr. 26	PU
IGC-AD1'S Interim Phase 2 Data Show a Reduction in Alzheimer's Agitation at Week Two	Apr. 17	AQ
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two	Apr. 16	BU
IGC Pharma Adds Advisor in Artificial Intelligence	Apr. 09	BU
IGC Pharma : Announces Positive Interim Results for IGC-AD1 in - Form 8-K	Apr. 05	PU
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock	Mar. 26	BU
IGC Pharma : Material Agreement - Form 8-K	Mar. 22	PU
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer's Agitation	Mar. 21	AQ
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation	Mar. 20	BU
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024	Mar. 20	BU
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline	Mar. 12	BU
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model	Feb. 28	BU
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target	Feb. 23	BU
IGC Pharma Reports Third Quarter Fiscal 2024 Results	Feb. 16	BU
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model	Feb. 01	BU
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s	Jan. 23	BU
IGC Pharma Activates ClinCloud, One of 12 Sites In Ongoing Phase 2b Alzheimer's Trial	Jan. 18	AQ
IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial	Jan. 17	BU
Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s	Dec. 19	BU
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024	Dec. 13	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases India Globalization Capital, Inc. Nyse

Equities

US45408X1000

Press Releases

Filters